Selected article for: "lung injury and NGAL expression"

Author: Zhang, Fangming; Brenner, Max; Yang, Weng-Lang; Wang, Ping
Title: A cold-inducible RNA-binding protein (CIRP)-derived peptide attenuates inflammation and organ injury in septic mice
  • Cord-id: ofsjs3nn
  • Document date: 2018_2_12
  • ID: ofsjs3nn
    Snippet: Cold-inducible RNA-binding protein (CIRP) is a novel sepsis inflammatory mediator and C23 is a putative CIRP competitive inhibitor. Therefore, we hypothesized that C23 can ameliorate sepsis-associated injury to the lungs and kidneys. First, we confirmed that C23 dose-dependently inhibited TNF-α release, IκBα degradation, and NF-κB nuclear translocation in macrophages stimulated with CIRP. Next, we observed that male C57BL/6 mice treated with C23 (8 mg/kg BW) at 2 h after cecal ligation and p
    Document: Cold-inducible RNA-binding protein (CIRP) is a novel sepsis inflammatory mediator and C23 is a putative CIRP competitive inhibitor. Therefore, we hypothesized that C23 can ameliorate sepsis-associated injury to the lungs and kidneys. First, we confirmed that C23 dose-dependently inhibited TNF-α release, IκBα degradation, and NF-κB nuclear translocation in macrophages stimulated with CIRP. Next, we observed that male C57BL/6 mice treated with C23 (8 mg/kg BW) at 2 h after cecal ligation and puncture (CLP) had lower serum levels of LDH, ALT, IL-6, TNF-α, and IL-1β (reduced by ≥39%) at 20 h after CLP compared with mice treated with vehicle. C23-treated mice also had improved lung histology, less TUNEL-positive cells, lower serum levels of creatinine (34%) and BUN (26%), and lower kidney expression of NGAL (50%) and KIM-1 (86%). C23-treated mice also had reduced lung and kidney levels of IL-6, TNF-α, and IL-1β. E-selectin and ICAM-1 mRNA was significantly lower in C23-treated mice. The 10-day survival after CLP of vehicle-treated mice was 55%, while that of C23-treated mice was 85%. In summary, C23 decreased systemic, lung, and kidney injury and inflammation, and improved the survival rate after CLP, suggesting that it may be developed as a new treatment for sepsis.

    Search related documents:
    Co phrase search for related documents
    • abdominal sepsis and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal sepsis and acute kidney injury: 1
    • abdominal sepsis and administration co: 1
    • absence presence and acute aki kidney injury: 1, 2, 3
    • absence presence and acute ali lung injury: 1, 2, 3
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute kidney injury: 1, 2, 3, 4, 5, 6, 7
    • absence presence and adherent cell: 1
    • absence presence and adhesion molecule: 1, 2, 3, 4
    • absence presence and administration co: 1, 2
    • absence presence and administration dose: 1, 2
    • activation marker and acute ards respiratory distress syndrome: 1, 2
    • activation marker and adhesion molecule: 1
    • activation marker and administration co: 1
    • acute aki kidney injury and adhesion molecule: 1
    • acute aki kidney injury and administration co: 1
    • acute ali lung injury and adhesion molecule: 1
    • acute ali lung injury and adjuvant treatment: 1, 2
    • acute ali lung injury and administration increase: 1